Immunology

Version vom 1. Juli 2020, 05:37 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Antibody-dependent enhancement

32361326 2020. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.

32268188 ä. It is too soon to attribute ADE to COVID-19

32346094 ä. COVID-19 vaccine design: the Janus face of immune enhancement
32303697 ä. Will we see protection or reinfection in COVID-19?
32438257 2020. SARS-CoV-2 and enhancing antibodies

32436320 2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
32506725 2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.
32529906 2020. Serological differentiation between COVID-19 and SARS infections.
32380903 2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.
32426212 2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
32526272 2020. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.

Herd immunity

32438622 2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
32391855 2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
32510562 2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
32418947 2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?
32372779 2020. Do you become immune once you have been infected?
32433946 2020. Herd Immunity: Understanding COVID-19.
32509257 2020. SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)?
32397700 2020. [Analysis of application of herd immunity as a control strategy for COVID-19].

Neutralizing antibodies

32454513 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
32454512 2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.
32497196 2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.

32515685 2020. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.

Innate sensing

32198201 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution

32456409 2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.

32524333 2020. COVID 19: a clue from innate immunity.
32464098 2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?

integrative work

• rev. on covid immunology

32205856 2020. COVID-19 infection: the perspectives on immune responses
32359396 ä. A Dynamic Immune Response Shapes COVID-19 Progression
C7064018 ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

32505227 2020. Immunology of COVID-19: Current State of the Science.
32469225 2020. COVID-19 and the immune system.

32507543 2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.

32493812 2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
32470151 2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.
32472706 2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
32213336 ä. SARS-CoV-2: virus dynamics and host response
32437933 2020. Viral dynamics in asymptomatic patients with COVID-19.
32407836 2020. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.
32498686 2020. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
32514817 2020. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
32460144 2020. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.
32417709 2020. Mechanism of inflammatory response in associated comorbidities in COVID-19.
32444400 2020. COVID-19 and the nicotinic cholinergic system.
32413330 2020. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
32514174 2020. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
32489708 2020. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).
32396996 2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.

covid modulates the immune system

32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China

32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

32463803 2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
32492165 2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
32514592 2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.
32456696 2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.
32502135 2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.
32532524 2020. SARS-CoV-2-A Tough Opponent for the Immune System.
32416070 2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
32513989 2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.

immune cell subpopulations

32282871 ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
32325421 2020. Increased expression of CD8 marker on T-cells in COVID-19 patients
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32346099 ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
32196410 2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune changes in patients with viral pneumonia
32333914 ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
32344320 ä. The clinical course and its correlated immune status in COVID-19 pneumonia
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
32343510 2020. COVID-19: are T lymphocytes simply watching?
32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32352397 2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32407057 2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32370466 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32114745 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

32458561 2020. Lymphopenia in COVID-19: Therapeutic opportunities.
32420610 2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
32470153 2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
32474608 2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.
32483488 2020. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.
32382776 2020. Signals of Th2 immune response from COVID-19 patients requiring intensive care.
32417210 2020. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
32405080 2020. Decreased T cell populations contribute to the increased severity of COVID-19.
32407466 2020. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.

t cell exhaustion

32249845 ä. Fighting COVID-19 exhausts T cells
32479985 2020. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.

32414395 2020. COVID-19: room for treating T cell exhaustion?
32425950 2020. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).

nk cells

32382127 ä. NKG2A and COVID-19: another brick in the wall
32344314 2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

plasmacytoid dendritic cells

32298486 2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)

antiviral immune response

32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32353870 2020. The many faces of the anti-COVID immune response
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19
31981224 2020. Coronavirus infections and immune responses
32198005 2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
32284614 ä. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
32355329 ä. SARS-CoV-2-reactive T cells in patients and healthy donors
32346091 ä. Neutralizing antibody response in mild COVID-19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis

32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32382126 ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients
32200654 2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
32476607 2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
32449333 2020. (+)Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.
32430094 2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
32467617 2020. Serum IgA, IgM, and IgG responses in COVID-19.

32398307 2020. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
32425634 2020. The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection.
32383183 2020. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.
32521002 2020. Antibody profiles in mild and severe cases of COVID-19.
32399213 2020. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.
32515684 2020. Patterns of IgG and IgM antibody response in COVID-19 patients.

32439770 2020. T cells found in coronavirus patients 'bode well' for long-term immunity.

32513850 2020. Early Insights into Immune Responses during COVID-19.

antiviral mediators

32422144 2020. Perforin and resistance to SARS coronavirus 2.

mediators

32360285 ä. Type I IFN immunoprofiling in COVID-19 patients

30715745 2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study
32414693 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection

32437622 2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.
32475759 2020. IL-6: Relevance for immunopathology of SARS-CoV-2.

immunopathology

32371101 ä. The correlation between SARS-CoV-2 infection and rheumatic disease
32205186 2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
32308263 2020. CoViD-19 Immunopathology and Immunotherapy
32320677 ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32282863 ä. Molecular immune pathogenesis and diagnosis of COVID-19
32321823 2020. COVID-19: an Immunopathological View
32273594 ä. COVID-19: immunopathology and its implications for therapy
32303696 ä. Macrophages: a Trojan horse in COVID-19?

32423059 2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.
32485101 2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
32423917 2020. COVID-19 as an Acute Inflammatory Disease.

32398875 2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
32391668 2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].

32460357 2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.

32389590 2020. COVID-19: Unanswered questions on immune response and pathogenesis.
32422146 2020. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
32521376 2020. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
32470851 2020. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.
32454103 2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.
32398804 2020. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?

secondary autoimmunity

32292901 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32315487 2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19

32389543 ä. COVID-19 and molecular mimicry: The Columbus? egg?
32444414 2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.

32535093 2020. Covid-19 and autoimmunity.
32461193 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.

Thymus

32340873 ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype
32317217 ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype

Eosinopenia, Eosinophilia

32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32344056 ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
32369190 2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series

32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
32390402 2020. SARS-CoV-2 and Eosinophilia.

microbiome

32497191 2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.

32432790 2020. Editorial - COVID-19 and the microbiota: new kids on the block.
32442562 2020. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.

009

32410760 2020. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
32410759 2020. Kawasaki-like disease: emerging complication during the COVID-19 pandemic.
32534627 2020. Have deaths from COVID-19 in Europe plateaued due to herd immunity?
32534626 2020. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
32246939 2020. SARS-CoV-2 in wastewater: potential health risk, but also data source.
32220289 2020. Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility.
32386610 2020. Prevention of the cytokine storm in COVID-19.
32526193 2020. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
32526191 2020. Pathologists in pursuit of the COVID-19 culprit.
32470417 2020. COVID-19 international neurological registries.
32386571 2020. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
32386570 2020. Assessment of SARS-CoV-2 replication in the context of other respiratory viruses.
32473124 2020. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
32473123 2020. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission.
32446313 2020. Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.
32422178 2020. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
32422177 2020. Pulmonary fibrosis secondary to COVID-19: a call to arms?
32427161 2020. Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms.
32483300 2020. SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells.
32502542 2020. The immune system and COVID-19: Friend or foe?
32430402 2020. Could severe COVID-19 be considered a complementopathy?
32284797 2020. We have to write and share valid and reliable information on COVID-19.
32535228 2020. Structural analysis of the putative SARS-CoV-2 primase complex.
32398026 2020. Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.
32522207 2020. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
32487093 2020. The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.
31712093 2020. Rapid manipulation of the porcine epidemic diarrhea virus genome by CRISPR/Cas9 technology.
32405428 2020. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8-11 March 2020, Boston, USA.
32437497 2020. Postmortem Examination of Patients With COVID-19.
32412415 2020. A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.
32461141 2020. The case of Complement activation in COVID-19 multiorgan impact.
32446936 2020. Electron Microscopic Investigations in COVID-19: Not all Crowns Are Coronas.
32525010 2020. Thrombotic microangiopathy in a patient with COVID-19.
32437766 2020. Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19.
32437765 2020. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19.
32426558 2020. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: a case against "SARS-CoV-2 nephropathy".
32442529 2020. Electron microscopy of SARS-CoV-2: a challenging task.
32442527 2020. Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
32464112 2020. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
32446324 2020. Detection of SARS-CoV-2 in human breastmilk.
32482418 2020. Research during SARS-CoV-2 pandemic: To "Preprint" or not to "Preprint", that is the question.
32395713 2020. Melatonin Inhibits COVID-19-induced Cytokine Storm by Reversing Aerobic Glycolysis in Immune Cells: A Mechanistic Analysis.
32504925 2020. What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
32464496 2020. Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19.
32505066 2020. COVID-19: Loss of bridging between innate and adaptive immunity?
32460210 2020. "Therapeutic" facemasks.
32425304 2020. Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?
32447232 2020. COVID-19: beta-thalassemia subjects immunised?
32534341 2020. Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?
32534340 2020. The intriguing commonality of NETosis between COVID-19 & Periodontal disease.
32534339 2020. A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?
32505073 2020. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression.
32445664 2020. COVID-19 as a cause of immune thrombocytopenia.
32391393 2020. Digesting the crisis: autophagy and coronaviruses.
32405236 2020. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.
32446902 2020. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.
32425647 2020. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency.
32381617 2020. Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru.
32467284 2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt.
32467283 2020. Complete Genome Sequence of SARS-CoV-2 in a Tiger from a U.S. Zoological Collection.
32409547 2020. Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia.
32527780 2020. Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh.
32501301 2020. A rapid screening method for testing the efficiency of masks in breaking down aerosols.
32531352 2020. Importance of the evaluation of systemic microvascular flow and reactivity in critically ill patients with coronavirus disease 2019 - COVID-19.
32393381 2020. Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey.
32518047 2020. Cadaverless anatomy: Darkness in the times of pandemic Covid-19.
32427981 2020. Organoids demonstrate gut infection by SARS-CoV-2.
32461674 2020. The non-specific and sex-differential effects of vaccines.
32461672 2020. Kawasaki disease linked to COVID-19 in children.
32461671 2020. Innate T cells in COVID-19: friend or foe?
32457522 2020. Dysregulation of type I interferon responses in COVID-19.
32439870 2020. COVID-19: the vasculature unleashed.
32409742 2020. SARS-CoV-2 likes it cool.
32409741 2020. Modulation of immune crosstalk in COVID-19.
32514035 2020. Dissecting antibody-mediated protection against SARS-CoV-2.
32504061 2020. SARS-CoV-2 cross-reactivity in healthy donors.
32504060 2020. Immune evasion via SARS-CoV-2 ORF8 protein?
32504059 2020. Many paths to COVID-19 lymphocyte dysfunction.
32488201 2020. Blood clots and TAM receptor signalling in COVID-19 pathogenesis.
32533111 2020. A versatile mouse model of COVID-19.
32533110 2020. SARS-CoV-2 has a sweet tooth.
32528136 2020. Considering how biological sex impacts immune responses and COVID-19 outcomes.
32415242 2020. A spike with which to beat COVID-19?
32488173 2020. Antimicrobial use, drug-resistant infections and COVID-19.
32528128 2020. Bat-borne virus diversity, spillover and emergence.
32483314 2020. COVID-19: organoids go viral.
32445105 2020. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
32509310 2020. Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations.
32483490 2020. The role of selectivity of the SARS-CoV-2 virus for human genetic profiles in susceptibility and resistance to COVID-19.
32292587 2020. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future.
32427206 2020. Rare and extreme events: the case of COVID-19 pandemic.
32425360 2020. Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases.
32409839 2020. Physician deaths from corona virus (COVID-19) disease.
32532805 2020. Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.
32519118 2020. Okulare Post-mortem-Befunde bei an COVID-19 verstorbenen Patienten.
32412525 2020. The Myriad Ways in Which COVID-19 Revealed Character.
32528816 2020. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea.
32528815 2020. Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome.
32397138 2020. A Systematic Review Analyzing the Prevalence and Circulation of Influenza Viruses in Swine Population Worldwide.
32529358 2020. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital.
32509472 2020. Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions.
32464327 2020. COVID-19 and Kawasaki disease in children.
32447571 2020. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.
32462744 2020. Shortlisting SARS-CoV-2 Peptides for Targeted Studies from Experimental Data-Dependent Acquisition Tandem Mass Spectrometry Data.
32405877 2020. A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
32466999 2020. COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?
32515676 2020. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.
32399393 2020. The potential role of TNFalpha in 2019 novel coronavirus pneumonia.
32415310 2020. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19).
32533292 2020. Targeting the immunology of coronavirus disease-19: synchronization creates symphony.
32445403 2020. SARS-CoV-2 infection-induced immune responses: Friends or foes?
32434946 2020. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
32513865 2020. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California.
32388537 2020. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro).
32435059 2020. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
32532959 2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin.
32399806 2020. Is COVID-19 a New Hematologic Disease?
32500482 2020. Induced Pluripotent Stem Cells (iPSCs) Derived 3D Human Lung Organoids from Different Ethnicities to Understand the SARS-CoV2 Severity/Infectivity Percentage.
32528206 2020. COVID-19 and lessons learned from the pandemic wave of meningococcal meningitis (1985-1990).
32528193 2020. The Sudanese/British doctors who offered their lives fighting coronavirus (COVID-19) pandemic.
32505009 2020. ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.
32387238 2020. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
32473312 2020. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis.
32317245 2020. Ger Rijkers: Persistence of Memory in Times of COVID-19.
32423553 2020. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection.
32500504 2020. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
32434416 2020. Mice with humanized-lungs and immune system - an idealized model for COVID-19 and other respiratory illness.
32431949 2020. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.
32531235 2020. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
32430279 2020. Gut microbiota and Covid-19- possible link and implications.
32417181 2020. COVID-19: CADD to the rescue.
32416259 2020. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2.
32517266 2020. Propagation, Inactivation, and Safety Testing of SARS-CoV-2.
32512929 2020. The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities. some other papers
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32504103 2020. Ten things we learned about COVID-19.
32494929 2020. COVID-19: 10 things I wished I'd known some months ago.
32437740 2020. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.
32510470 2020. Is innate immunity our best weapon for flattening the curve?
32464309 2020. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.
32398780 2020. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.
32534002 2020. Cancer population may be paradoxically protected from severe manifestations of COVID-19.
32360499 2020. Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.
32283147 2020. Prolonged virus shedding even after seroconversion in a patient with COVID-19.

32412125 2020. Androgen sensitivity gateway to COVID-19 disease severity.
32393438 2020. Intelligent classification of platelet aggregates by agonist type.
32444797 2020. BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.
32415272 2020. Connecting data, tools and people across Europe: ELIXIR's response to the COVID-19 pandemic.
32376989 2020. The VODAN IN: support of a FAIR-based infrastructure for COVID-19.
32335973 2020. Of mice and men: COVID-19 challenges translational neuroscience.
32510005 2020. COVID-19 target: A specific target for novel coronavirus detection.
32526937 2020. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.
32437706 2020. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
32392464 2020. SARS-CoV-2: Combating Coronavirus Emergence.
32473952 2020. SARS-CoV-2: The viral shedding vs infectivity dilemma.
32450246 2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.
32405281 2020. Sars-CoV-2 and black population: ACE2 as shield or blade?
32524515 2020. Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.
32485251 2020. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.
31896597 2020. Host AAA+ ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis.
32528156 2020. Ten recommendations for supporting open pathogen genomic analysis in public health.
32467367 2020. Scientists put survivors' blood plasma to the test.
32496715 2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]
32455617 2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.
32512133 2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
32512089 2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.
32470223 2020. COVID-19: Structural Predictions of Viral Success.
32423901 2020. How covid-19 is accelerating the threat of antimicrobial resistance.
32504123 2020. COVID-19 research: toxicological input urgently needed!
32412787 2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.
32213337 ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32235915 ä. COVID-19: a new challenge for human beings

32376309 2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
32388390 2020. The powerful immune system against powerful COVID-19: A hypothesis
32372807 2020. The fever paradox
32220035 2020. SARS-CoV-2: What do we know so far?
32534452 2020. From causes of aging to death from COVID-19.
32489698 2020. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.
32401346 2020. SARS-CoV-2 immunogenicity at the crossroads.
32053148 2020. Three Emerging Coronaviruses in Two Decades.
32516444 2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.
32439309 2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.

32458383 2020. On barring the vascular gateway against severe COVID-19 disease.
32526483 2020. COVID 19 and brain crosstalks.
32533824 2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
32425712 2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.